FGF-23, hsCRP, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS Trial | JACC: Advances
Dec 24, 2025
3:08
Episode Description
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on FGF-23, hsCRP, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS Trial.
Proudly Supported by
Patrons of Health Podcast Library
Supporting Shows
